In androgen-dependent prostate carcinoma, TRPM8 seems to act as an inhibitor of the migration of prostate cancer cells by inactivating focal adhesion kinase in conjunction with partner proteins [52,53]. Here, TRPM8 is linked to prostate carcinoma.